Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2018;7(1): 7-10. doi:
10.15171/jrip.2018.02
Mini-Review
Metformin; a mini-review to its antioxidative and anti-inflammatory properties
Abolfazl Abbaszadeh
1
, Sahar Koushki
2
, Shirin Koushki
2
, Marzieh Eskandarzadeh
2
, Amin Hasanvand
3
*
Cited by CrossRef: 3
1- Kluck G, Wendt C, Imperio G, Araujo M, Atella T, da Rocha I, Miranda K, Atella G. Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway.
Sci Rep
. 2019;9(1)
[Crossref]
2- Omar Z, Ahmed A, El-Bakry M, Ahmed M, Hasan A. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.
Annales Pharmaceutiques Françaises
. 2022;80(5):659
[Crossref]
3- Yew W, Chang K, Chan D, Zhang Y. Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?.
Tuberculosis
. 2019;115:76
[Crossref]